As the CEO of ImmunoMetabolix, Vladimir combines the two for an opportunity to provide extraordinary outcomes for patients, caregivers, providers, advocacy groups, payers, and overall stakeholders. ImmunoMetabolix is a clinical-stage biotechnology..
Relevance: 17.6236